Showing results (611-620 of 652) with videos related to

Sort By:
Pageof 66
Haematologica|January 19, 2019
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosisMarie Robin, Sylvie Chevret, Linda Koster, et al.
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.
Haematologica|October 16, 2012
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemiaFlorence Nguyen-Khac, Jerome Lambert, Elise Chapiro, et al.
The Lancet. Neurology|March 14, 2015
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trialRonit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
Orphanet Journal of Rare Diseases|October 26, 2018
Recent advances in methodology for clinical trials in small populations: the InSPiRe projectTim Friede, Martin Posch, Sarah Zohar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trialBernard Rio, Sylvie Chevret, Stéphane Vigouroux, et al.
Intensive Care Medicine|July 12, 2003
Family participation in care to the critically ill: opinions of families and staffElie Azoulay, Frédéric Pochard, Sylvie Chevret, et al.
British Journal of Haematology|April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutationsLionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 2009
Prevalence and factors of intensive care unit conflicts: the conflicus studyElie Azoulay, Jean-François Timsit, Charles L Sprung, et al.
BMC Pharmacology & Toxicology|November 9, 2017
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)Célia Lloret-Linares, Youssef Daali, Sylvie Chevret, et al.
Pageof 66